Clinical Trial Update: A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 first-in-human trial evaluating OKN4395 in combination with pembrolizumab in patients with solid tumors is currently recruiting. The study spans multipl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Dedifferentiated Liposarcoma
• Head and Neck Squamous Cell Carcinoma
• Myxofibrosarcoma
• Non-small Cell Lung Cancer
• Pancreatic Adenocarcinoma
• Solitary Fibrous Tumor
• Undifferentiated Pleomorphic Sarcoma

Drugs mentioned

• OKN4395
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Epkin | Conditions: Solid Tumours, Sarcoma | Phase 1 | Status: RECRUITING